// App-Quantinova.ai

37 EP404 : Effect of liraglutide 1.8 mg in patients with non-controlled type 2 diabetes mellitus at an endocrinology clinic: LIED-2 Study

Researchers

Presenter

  • Alvaro A Herrera

Principal Investigators

  • Alin Abreu Lomba

Medical Centers

  • Universidad Libre, Cali, Valle del Cauca, Colombia

  • Centro Medico Imbanaco, Cali, Valle Delcauca, Colombia

Locations

  • Colombia

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • GC Vitamin D Binding Protein

  • Hemoglobin A1c

  • Sex hormone binding globulin

Drug/Treatment

  • Liraglutide

  • Metformin Hydrochloride

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved